Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Operating Leases (2019 - 2024)

Historic Operating Leases for HUTCHMED (China) (HCM) over the last 6 years, with Q4 2024 value amounting to $325000.0.

  • HUTCHMED (China)'s Operating Leases rose 11855.02% to $325000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $325000.0, marking a year-over-year increase of 11855.02%. This contributed to the annual value of $325000.0 for FY2024, which is 11855.02% up from last year.
  • Per HUTCHMED (China)'s latest filing, its Operating Leases stood at $325000.0 for Q4 2024, which was up 11855.02% from -$1.8 million recorded in Q4 2023.
  • Over the past 5 years, HUTCHMED (China)'s Operating Leases peaked at $6.5 million during Q1 2021, and registered a low of -$1.8 million during Q4 2023.
  • Over the past 5 years, HUTCHMED (China)'s median Operating Leases value was $2.7 million (recorded in 2022), while the average stood at $2.4 million.
  • In the last 5 years, HUTCHMED (China)'s Operating Leases surged by 233564.36% in 2020 and then tumbled by 16486.49% in 2023.
  • Over the past 5 years, HUTCHMED (China)'s Operating Leases (Quarter) stood at $2.3 million in 2020, then soared by 36.36% to $3.1 million in 2021, then dropped by 12.28% to $2.7 million in 2022, then crashed by 164.86% to -$1.8 million in 2023, then skyrocketed by 118.55% to $325000.0 in 2024.
  • Its Operating Leases stands at $325000.0 for Q4 2024, versus -$1.8 million for Q4 2023 and $2.7 million for Q4 2022.